Significant increase in volume has been observed in Anuh Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Anuh Pharma Limited has submitted their response.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma clarified to NSE the reasons behind a recent spike in its share trading volume. The company attributed the increased activity to two recent developments: (1) a completed bonus issue of equity shares in a 1:1 ratio, and (2) the inauguration of a new manufacturing block at Tarapur, Boisar (Maharashtra) on July 15, 2025, which is expected to boost capacity to meet growing demand. The company confirmed there is no other undisclosed material information and assured continued compliance with SEBI listing regulations.
This is a routine clarification rather than a negative event. The bonus issue and new plant expansion are positive fundamentals that may justify higher trading interest. No negative action is implied, and the stock is unlikely to face any regulatory action based on this filing.